Crocs (CROX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

30.10.25 14:30 Uhr

Werte in diesem Artikel
Aktien

71,42 EUR -1,59 EUR -2,18%

Crocs (CROX) reported $996.3 million in revenue for the quarter ended September 2025, representing a year-over-year decline of 6.2%. EPS of $2.92 for the same period compares to $3.60 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $968.06 million, representing a surprise of +2.92%. The company delivered an EPS surprise of +22.18%, with the consensus EPS estimate being $2.39.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Crocs performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Revenues- Crocs Brand: $836.23 million compared to the $822.52 million average estimate based on three analysts. The reported number represents a change of -2.6% year over year.Revenues- HEYDUDE Brand: $160.07 million versus the three-analyst average estimate of $146.11 million. The reported number represents a year-over-year change of -21.6%.Revenues By Channel- HEYDUDE Brand- Wholesale: $69.4 million versus $65.23 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -38.6% change.Revenues By Channel- Crocs Brand- Direct-to-Consumer: $471.87 million compared to the $435.98 million average estimate based on two analysts. The reported number represents a change of +2% year over year.Revenues By Channel- HEYDUDE Brand- Direct-to-Consumer: $90.67 million compared to the $82.99 million average estimate based on two analysts. The reported number represents a change of -0.5% year over year.Revenues By Channel- Crocs Brand- Wholesale: $364.36 million compared to the $390.2 million average estimate based on two analysts. The reported number represents a change of -7.9% year over year.View all Key Company Metrics for Crocs here>>>Shares of Crocs have returned -0.4% over the past month versus the Zacks S&P 500 composite's +3.6% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.Zacks' Research Chief Picks Stock Most Likely to "At Least Double"Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.See Our Top Stock to Double (Plus 4 Runners Up) >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Crocs, Inc. (CROX): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: CROCS und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf CROCS

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf CROCS

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu CROCS Inc.

Wer­bung

Analysen zu CROCS Inc.

DatumRatingAnalyst
28.02.2019CROCS BuyMonness, Crespi, Hardt & Co.
15.01.2019CROCS BuyPivotal Research Group
09.11.2018CROCS BuyPivotal Research Group
06.11.2018CROCS BuyPivotal Research Group
25.07.2018CROCS BuyPivotal Research Group
DatumRatingAnalyst
28.02.2019CROCS BuyMonness, Crespi, Hardt & Co.
15.01.2019CROCS BuyPivotal Research Group
09.11.2018CROCS BuyPivotal Research Group
06.11.2018CROCS BuyPivotal Research Group
25.07.2018CROCS BuyPivotal Research Group
DatumRatingAnalyst
02.05.2018CROCS HoldPivotal Research Group
10.01.2018CROCS HoldPivotal Research Group
10.11.2016CROCS NeutralMonness, Crespi, Hardt & Co.
03.01.2012CROCS neutralRobert W. Baird & Co. Incorporated
19.10.2011CROCS neutralD.A. Davidson & Co.
DatumRatingAnalyst
18.09.2006Update CROCS Inc.: SellMatrix Research

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für CROCS Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen